Mylan CEO faces backlash over EpiPen prices

Mylan CEO Heather Bresch faced bipartisan backlash for her company’s pricing and revenue strategy on Wednesday on Capitol Hill. The price of EpiPens has …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.